Myocardial infarct size and mortality depend on the time of day-a large multicenter study

Stephane Fournier1, Patrick Taffé2, Dragana Radovanovic3

  • 1Department of Cardiology, University Hospital Center (CHUV), Lausanne, Switzerland.

Plos One
|March 12, 2015
PubMed

Insights

This study reveals a daily pattern in heart attack size and patient survival, independent of symptom duration. Heart attack onset time impacts outcomes, suggesting its use in prognosis.

Area of Science:

  • Cardiology
  • Chronobiology
  • Public Health

Background:

  • Previous research indicates variable circadian patterns in ST-Elevation Myocardial Infarction (STEMI) ischemic burden.
  • Conflicting results necessitate further investigation into daily variations in STEMI outcomes.

Purpose of the Study:

  • To investigate the circadian variation in myocardial infarction size and in-hospital mortality.
  • To analyze these variations in a large, multicenter registry of STEMI patients.

Main Methods:

  • Retrospective analysis of the AMIS Plus Swiss registry (1999-2013).
  • Peak creatine kinase (CK) used as a proxy for myocardial infarction size.
  • Polynomial-harmonic regression modeled associations between peak CK, mortality, and symptom onset time.

Main Results:

  • A significant 24-hour harmonic pattern was observed for both peak CK and in-hospital mortality.
  • Peak myocardial infarction size was highest for symptom onset at 23:00 and lowest at 11:00.
  • In-hospital mortality risk was highest for symptom onset at 00:00 and lowest at 12:00, independent of ischemic time.

Conclusions:

  • Confirmed a circadian pattern in peak CK and in-hospital mortality for STEMI patients treated with primary angioplasty.
  • This circadian variation is independent of total ischemic time.
  • Recommends incorporating symptom onset time as a prognostic factor in myocardial infarction management.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
488
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
482
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.8K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
499
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
622